Carl Dambkowski's most recent trade in Apogee Therapeutics Inc. was a trade of 7,365 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Apogee Therapeutics Inc. | Carl Dambkowski | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jul 2025 | 7,365 | 164,010 | - | - | Stock Option (Right to Buy) | |
| Apogee Therapeutics Inc. | Carl Dambkowski | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.86 per share. | 02 Jul 2025 | 7,365 | 249,088 | - | 22.9 | 168,364 | Common Stock |
| Apogee Therapeutics Inc. | Carl Dambkowski | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 44.77 per share. | 02 Jul 2025 | 6,409 | 242,679 | - | 44.8 | 286,931 | Common Stock |
| Apogee Therapeutics Inc. | Carl Dambkowski | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 45.49 per share. | 02 Jul 2025 | 2,935 | 239,744 | - | 45.5 | 133,513 | Common Stock |
| Apogee Therapeutics Inc. | Carl Dambkowski | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 46.26 per share. | 02 Jul 2025 | 746 | 238,998 | - | 46.3 | 34,510 | Common Stock |
| Apogee Therapeutics Inc. | Carl Dambkowski | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 36.96 per share. | 04 Jun 2025 | 2,725 | 241,723 | - | 37.0 | 100,716 | Common Stock |
| Oruka Therapeutics Inc. | Carl Dambkowski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 17,500 | 17,500 | - | - | Stock Option (right to buy) | |
| Apogee Therapeutics Inc. | Carl Dambkowski | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 35.75 per share. | 07 May 2025 | 2,725 | 244,448 | - | 35.8 | 97,419 | Common Stock |
| Apogee Therapeutics Inc. | Carl Dambkowski | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 35.56 per share. | 02 Apr 2025 | 2,471 | 248,562 | - | 35.6 | 87,869 | Common Stock |
| Apogee Therapeutics Inc. | Carl Dambkowski | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 37.59 per share. | 02 Apr 2025 | 889 | 247,173 | - | 37.6 | 33,418 | Common Stock |
| Apogee Therapeutics Inc. | Carl Dambkowski | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 37.03 per share. | 02 Apr 2025 | 500 | 248,062 | - | 37.0 | 18,515 | Common Stock |
| Apogee Therapeutics Inc. | Carl Dambkowski | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 30.48 per share. | 05 Mar 2025 | 1,590 | 251,033 | - | 30.5 | 48,463 | Common Stock |
| Apogee Therapeutics Inc. | Carl Dambkowski | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 40.69 per share. | 05 Feb 2025 | 3,520 | 252,623 | - | 40.7 | 143,229 | Common Stock |
| Apogee Therapeutics Inc. | Carl Dambkowski | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.86 per share. | 05 Feb 2025 | 795 | 256,143 | - | 22.9 | 18,174 | Common Stock |
| Apogee Therapeutics Inc. | Carl Dambkowski | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2025 | 795 | 171,375 | - | - | Stock Option (Right to Buy) | |
| Apogee Therapeutics Inc. | Carl Dambkowski | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 47.21 per share. | 02 Jan 2025 | 2,486 | 255,448 | - | 47.2 | 117,364 | Common Stock |
| Apogee Therapeutics Inc. | Carl Dambkowski | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 46.42 per share. | 02 Jan 2025 | 1,499 | 257,934 | - | 46.4 | 69,584 | Common Stock |
| Apogee Therapeutics Inc. | Carl Dambkowski | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.86 per share. | 02 Jan 2025 | 1,360 | 259,433 | - | 22.9 | 31,090 | Common Stock |
| Apogee Therapeutics Inc. | Carl Dambkowski | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2025 | 1,360 | 172,170 | - | - | Stock Option (Right to Buy) | |
| Apogee Therapeutics Inc. | Carl Dambkowski | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 47.92 per share. | 02 Jan 2025 | 100 | 255,348 | - | 47.9 | 4,792 | Common Stock |
| Apogee Therapeutics Inc. | Dambkowski Carl | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 48.62 per share. | 11 Dec 2024 | 4,085 | 258,528 | - | 48.6 | 198,613 | Common Stock |
| Apogee Therapeutics Inc. | Dambkowski Carl | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2024 | 1,815 | 173,530 | - | - | Stock Option (Right to Buy) | |
| Apogee Therapeutics Inc. | Dambkowski Carl | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.86 per share. | 11 Dec 2024 | 1,815 | 262,613 | - | 22.9 | 41,491 | Common Stock |
| Apogee Therapeutics Inc. | Dambkowski Carl | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 11 Dec 2024 | 455 | 258,073 | - | 50 | 22,750 | Common Stock |
| Apogee Therapeutics Inc. | Carl Dambkowski | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2024 | 124,962 | 124,962 | - | - | Stock Option (Right to Buy) | |
| Apogee Therapeutics Inc. | Carl Dambkowski | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 46.07 per share. | 04 Dec 2024 | 6,665 | 260,798 | - | 46.1 | 307,057 | Common Stock |
| Apogee Therapeutics Inc. | Carl Dambkowski | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 58.91 per share. | 06 Nov 2024 | 5,326 | 268,802 | - | 58.9 | 313,755 | Common Stock |
| Apogee Therapeutics Inc. | Carl Dambkowski | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 59.96 per share. | 06 Nov 2024 | 1,339 | 267,463 | - | 60.0 | 80,286 | Common Stock |
| Apogee Therapeutics Inc. | Carl Dambkowski | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 56.16 per share. | 02 Oct 2024 | 5,740 | 275,053 | - | 56.2 | 322,358 | Common Stock |
| Apogee Therapeutics Inc. | Carl Dambkowski | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 56.86 per share. | 02 Oct 2024 | 925 | 274,128 | - | 56.9 | 52,596 | Common Stock |
| Apogee Therapeutics Inc. | Carl Dambkowski | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 47.49 per share. | 04 Sep 2024 | 5,878 | 281,580 | - | 47.5 | 279,146 | Common Stock |
| Apogee Therapeutics Inc. | Carl Dambkowski | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 48.06 per share. | 04 Sep 2024 | 787 | 280,793 | - | 48.1 | 37,823 | Common Stock |
| Apogee Therapeutics Inc. | Carl Dambkowski | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 40.47 per share. | 07 Aug 2024 | 6,523 | 288,270 | - | 40.5 | 263,986 | Common Stock |
| Apogee Therapeutics Inc. | Carl Dambkowski | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 42.56 per share. | 07 Aug 2024 | 670 | 287,458 | - | 42.6 | 28,515 | Common Stock |
| Apogee Therapeutics Inc. | Carl Dambkowski | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 41.09 per share. | 07 Aug 2024 | 142 | 288,128 | - | 41.1 | 5,835 | Common Stock |
| Apogee Therapeutics Inc. | Carl Dambkowski | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 37.29 per share. | 03 Jul 2024 | 3,852 | 296,936 | - | 37.3 | 143,641 | Common Stock |
| Apogee Therapeutics Inc. | Carl Dambkowski | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 38.16 per share. | 03 Jul 2024 | 2,143 | 294,793 | - | 38.2 | 81,777 | Common Stock |
| Apogee Therapeutics Inc. | Carl Dambkowski | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2023 | 175,345 | 175,345 | - | - | Stock Option (Right to Buy) |